Yang Peng | Public Health Analytics | Research Excellence Award

Published on by Research Data Analysis

Dr. Yang Peng | Public Health Analytics | Research Excellence Award

The University of Queensland | Australia

Dr. Yang Peng is an accomplished epidemiologist and Research Fellow at the Epidemiology Division, Cancer Council Victoria, with a strong focus on population health, cardiovascular disease, and cancer epidemiology. He earned his PhD in Epidemiology from The University of Queensland, Australia, following an MMed in Epidemiology and Biostatistics from Guangdong Pharmaceutical University, China, and a BMed in Clinical Medicine from Hebei Medical University, China. Dr. Peng’s professional experience spans roles in cardiovascular outcomes research, Indigenous cancer survival studies, and large-scale international cohort analyses, involving data from over 2 million participants across multiple cohorts. His expertise includes statistical analysis of large-scale linked data, systematic review, meta-analysis, and advanced use of statistical software such as Stata, SAS, and SPSS. He has authored 41 documents, cited 667 times across 649 documents, and holds an h-index of 17, with publications in high-impact journals including Scientific Reports, Stroke, European Heart Journal, and Cancer Epidemiology, Biomarkers & Prevention. His research interests focus on lifestyle factors, cardiovascular health metrics, cancer prevention adherence, stroke and heart failure outcomes, and population-level survival disparities. Through rigorous research, collaborative projects, and evidence-based analyses, Dr. Peng contributes significantly to understanding disease epidemiology, improving public health policies, and guiding preventative strategies globally.

View Orcid Profile
 View Orcid Profile

Featured Publications

Georgia Kourlaba | Public Health Analytics | Research Excellence Award

Published on by Research Data Analysis

Assist. Prof. Dr. Georgia Kourlaba | Public Health Analytics | Research Excellence Award

 National & Kapodistrian University of Athens | Greece

Assist. Prof. Dr. Georgia Kourlaba is an accomplished public health nursing scholar, currently serving as Assistant Professor of Public Health Nursing – Prevention at the Department of Nursing, National and Kapodistrian University of Athens (NKUA). From 2022 to 2025, she was Assistant Professor of Research Methodology and Evidence-Based Nursing at the University of Peloponnese. She has also been an Academic Fellow at the 1st Intensive Care Unit of the Faculty of Medicine, NKUA, focusing on nosocomial infections and epidemiology, and is a founding member of the Center for Clinical Epidemiology and Outcomes Research (CLEO), where she served as Administrative Director and Deputy Scientific Director. Dr. Kourlaba is a member of the Public Health Experts Committee of the Ministry of Health, has held leadership roles at the National Public Health Organization (EODY), and served as an alternate member of the Management Board of the European Centre for Disease Prevention and Control (ECDC). She teaches epidemiology, research methodology, biostatistics, health technology assessment, and disease prevention at undergraduate and postgraduate levels. Her research focuses on nosocomial infections, antimicrobial resistance, vaccination coverage, chronic disease epidemiology, childhood obesity, and socioeconomic burden of disease. She has participated in numerous funded projects and published 166 documents cited 3,485 times, with an h-index of 33. Dr. Kourlaba holds an MSc in Biostatistics (NKUA) and a Ph.D. in Nutritional Epidemiology and Biostatistics (Harokopio University).

Profile : Scopus 

Featured Publications

(2026). HPV vaccination coverage among children and adolescents in Greece using national prescription data. Vaccine.

(2025). Real-world switching patterns and associated characteristics in patients with psoriasis treated with biologics. Archives of Dermatological Research.

(2025). QuantiFERON SARS-CoV-2 assay for the evaluation of cellular immunity after immunization with mRNA SARS-CoV-2 vaccines: A systematic review and meta-analysis. Immunologic Research.

(2025). Early discontinuation of empiric antibiotic therapy in children treated for cancer who develop febrile neutropenia: A prospective cohort study. EJC Paediatric Oncology.

(2025). Attitudes, behaviors, opinions, and suggestions of blood donors toward blood donation in Crete, Greece. Archives of Hellenic Medicine.

Wuzheng Zhu | Qualitative Research | Research Excellence Award

Published on by Research Data Analysis

Dr. Wuzheng Zhu | Qualitative Research | Research Excellence Award

College of Life Sciences | China

Dr. Wuzheng Zhu is a regenerative medicine researcher, specializing in mitochondrial biology, cellular repair, and stem‑cell therapies. He earned his Ph.D. in Biochemistry and Molecular Biology from Sichuan University’s Regenerative Medicine Research Center (West China Hospital). Currently based in the Laboratory of Animal Nutrition and Human Health, College of Life Sciences, Changsha, his work delves into the molecular mechanisms underlying mitochondrial homeostasis, particularly in the context of acute kidney injury and cardiovascular diseases. His lab combines biochemistry, molecular and cellular biology, drug screening, and mouse models to identify and manipulate mitochondrial regulation and repair pathways. Dr. Zhu has published extensively, with 5 documents, 306 citations, and an h‑index of 5, including influential studies on mesenchymal stem cell–mediated protection via mitophagy, mitochondrial dynamics in endothelial injury, lysosomal dysfunction in macrophage polarization, and suppression of ER stress in vascular cells. He has also investigated dietary intervention in piglet gut development. He is a recipient of the prestigious TTS‑CTRMS Scientific Congress Award in 2017. His research offers significant translational potential, aiming to harness mitochondrial modulation and stem-cell strategies for therapeutic intervention in metabolic and cardiovascular conditions.

Profile : Scopus

Featured Publications

Wei, J., Mao, R., Chen, Y., Si, K., Li, Y., Li, J., & Zhu, W. (2025). “MSCs ameliorates hyperglycemia-induced endothelial injury through modulation of mitochondrial dynamics” in Cell Death & Disease, 16(1), 832.

Mao, R.W., He, S.P., Lan, J.G., & Zhu, W.Z. (2022). “Honokiol ameliorates cisplatin‐induced acute kidney injury via inhibition of mitochondrial fission” in British Journal of Pharmacology.

Zhu, W., Yuan, Y., Liao, G., Li, L., Liu, J., Chen, Y., et al. (2018). “Mesenchymal stem cells ameliorate hyperglycemia-induced endothelial injury through modulation of mitophagy” in Cell Death & Disease, 9(8), 1–17.

Yuan, Y., Chen, Y., Peng, T., Li, L., Zhu, W., Liu, F., et al. (2019). “Mitochondrial ROS-induced lysosomal dysfunction impairs autophagic flux and contributes to M1 macrophage polarization in a diabetic condition” in Clinical Science, 133(15), 1759–1777.

Luo, R., Li, L., Liu, X., Yuan, Y., Zhu, W., Li, L., et al. (2020). “Mesenchymal stem cells alleviate palmitic acid-induced endothelial-to-mesenchymal transition by suppressing endoplasmic reticulum stress” in American Journal of Physiology-Endocrinology and Metabolism, 319(6), E961–E980.